337 related articles for article (PubMed ID: 26603103)
1. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Wickström M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjörnsson B; Sandén E; Darabi A; Siesjö P; Kool M; Kogner P; Baryawno N; Johnsen JI
Nat Commun; 2015 Nov; 6():8904. PubMed ID: 26603103
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
3. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
Hu YH; Jiao BH; Wang CY; Wu JL
CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
[TBL] [Abstract][Full Text] [Related]
4. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
5. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
6. In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.
Fruehauf JP; Brem H; Brem S; Sloan A; Barger G; Huang W; Parker R
Clin Cancer Res; 2006 Aug; 12(15):4523-32. PubMed ID: 16899598
[TBL] [Abstract][Full Text] [Related]
7. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
[TBL] [Abstract][Full Text] [Related]
8. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
[TBL] [Abstract][Full Text] [Related]
9. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
10. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
Cabrini G; Fabbri E; Lo Nigro C; Dechecchi MC; Gambari R
Int J Oncol; 2015 Aug; 47(2):417-28. PubMed ID: 26035292
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy.
Jiang G; Wei ZP; Pei DS; Xin Y; Liu YQ; Zheng JN
Biochem Biophys Res Commun; 2011 Mar; 406(3):311-4. PubMed ID: 21329652
[TBL] [Abstract][Full Text] [Related]
12. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
13. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells.
Li ZY; Huang GD; Chen L; Zhang C; Chen BD; Li QZ; Wang X; Zhang XJ; Li WP
Mol Med Rep; 2017 Nov; 16(5):5908-5914. PubMed ID: 28849207
[TBL] [Abstract][Full Text] [Related]
15. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
[TBL] [Abstract][Full Text] [Related]
16. O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.
Sasai K; Akagi T; Aoyanagi E; Tabu K; Kaneko S; Tanaka S
Mol Cancer; 2007 Jun; 6():36. PubMed ID: 17547775
[TBL] [Abstract][Full Text] [Related]
17. Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells.
Zhou Y; Chen L; Ding D; Li Z; Cheng L; You Q; Zhang S
Sci Rep; 2022 May; 12(1):7773. PubMed ID: 35545654
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide and MGMT forever?
Weller M
Neuro Oncol; 2010 Mar; 12(3):219-20. PubMed ID: 20167809
[No Abstract] [Full Text] [Related]
19. MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.
Altinoz MA; Elmaci I; Bolukbasi FH; Ekmekci CG; Yenmis G; Sari R; Sav A
J Chemother; 2017 Aug; 29(4):238-244. PubMed ID: 28436299
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide analog PMX 465 downregulates MGMT expression in HCT116 colorectal carcinoma cells.
Yang Z; Wei D; Liu F; Liu J; Wu X; Stevens MFG; Bradshaw TD; Luo Y; Zhang J
J Cell Biochem; 2018 Jul; 119(7):5350-5358. PubMed ID: 29331023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
